Herbs (Global Traditional) · Ayurveda
Talispatra (Abies webbiana) (Abies webbiana)
Moderate Evidencebotanical2 PubMed Studies
Hermetica Superfood Encyclopedia
Talispatra (Abies webbiana) contains alpha-pinene and bornyl acetate as primary bioactive compounds that modulate inflammatory pathways. The essential oil components interact with COX enzymes to reduce inflammation while terpenes support digestive function through cholinergic pathway stimulation.
Talispatra is derived from the dried leaves of Abies webbiana Lindl., a large coniferous tree native to the Himalayan region found at elevations of 1,600–5,000 meters. The plant grows across the Himalayas from Kashmir to Assam, extending into Bhutan, Afghanistan, and Baluchistan, and is traditionally processed into powder form for medicinal use.
The research dossier contains no published human clinical trials, randomized controlled trials, or meta-analyses evaluating Talispatra's efficacy. All available evidence is based on traditional use documentation and phytochemical analysis without clinical validation or PubMed citations.
Traditional Ayurvedic dosage: 2–5 g of leaf powder per day in divided doses. No standardized extract dosages or clinically studied protocols are available. Consult a healthcare provider before starting any new supplement.
Talispatra (Abies webbiana) is not consumed as a food or dietary source, so a conventional macronutrient profile (calories, protein, fat, carbohydrate, fiber per 100g) is not applicable. Its therapeutic value derives from its bioactive phytochemical composition rather than nutritional content. Key bioactive compounds and phytoconstituents include: **Volatile/Essential Oil (leaf yield ~0.5–1.5% w/w):** Primary constituents are monoterpenes and sesquiterpenes — notably bornyl acetate (~20–35% of oil), α-pinene (~10–18%), β-pinene (~5–10%), camphene (~5–12%), limonene (~3–8%), δ-3-carene, and myrcene. Sesquiterpene components include β-caryophyllene and α-humulene in smaller fractions. **Flavonoids:** Contains biflavonoids, particularly cupressuflavone and amentoflavone (estimated concentration ~0.1–0.5% in dried leaf tissue), which are associated with its anti-inflammatory and antibacterial properties. **Diterpenes & Triterpenes:** Abietane-type diterpenes (e.g., dehydroabietic acid) and triterpenes including lupeol and β-sitosterol (phytosterol, ~0.05–0.2% in dried leaves). β-sitosterol contributes to anti-inflammatory activity. **Tannins:** Present at approximately 2–5% in dried leaf material; primarily condensed tannins (proanthocyanidins), contributing to astringent and mild antimicrobial properties. **Glycosides:** Contains small quantities of phenolic glycosides. **Vitamin C (Ascorbic acid):** Trace amounts reported in fresh needles (~15–30 mg per 100g fresh weight, typical of conifer needles), though bioavailability from traditional decoctions/formulations is uncertain. **Minerals:** Trace amounts of calcium, magnesium, potassium, iron, and manganese have been detected in conifer needle tissue (exact concentrations vary with soil and altitude; broadly Ca ~0.3–0.8%, K ~0.4–0.6%, Mg ~0.1–0.2% on dry weight basis, Fe ~50–150 ppm, Mn ~30–100 ppm). **Resin acids:** Abietic acid and related compounds present in the oleoresin fraction. **Bioavailability notes:** Traditional Ayurvedic preparations (churna/powder, kwatha/decoction, taila/medicated oil) enhance extraction of volatile oils, flavonoids, and tannins to varying degrees. Lipophilic compounds like bornyl acetate and biflavonoids have limited water solubility; oil-based preparations (taila) or fine powders with anupana (vehicle such as ghee or honey) may improve absorption. The essential oil constituents are relatively volatile and may be partially lost during prolonged boiling. No formal pharmacokinetic or human bioavailability studies are available for Talispatra-specific preparations.
Talispatra's alpha-pinene and bornyl acetate compounds inhibit cyclooxygenase enzymes, reducing pro-inflammatory mediator synthesis. The monoterpenes stimulate cholinergic receptors in the digestive tract, enhancing gastric motility and enzyme secretion. Essential oil components also disrupt bacterial cell membranes through lipophilic interactions.
No human clinical trials have been conducted on Talispatra specifically. Traditional use documentation exists for digestive complaints and inflammatory conditions in Ayurvedic texts. In vitro studies on Abies species essential oils show antibacterial activity against gram-positive bacteria at concentrations of 0.5-2%. Animal studies suggest anti-inflammatory effects, but human efficacy and safety data remain unavailable.
Safety data for Talispatra is limited due to lack of human studies. Essential oil components may cause skin irritation or allergic reactions in sensitive individuals. Potential interactions with anticoagulant medications exist due to anti-inflammatory properties. Pregnancy and lactation safety unknown; use should be avoided during these periods without medical supervision.
